Eversept Partners as of March 31, 2020
Portfolio Holdings for Eversept Partners
Eversept Partners holds 65 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix | 12.6 | $50M | 2.0M | 24.73 | |
| Danaher Corporation (DHR) | 8.2 | $32M | 234k | 138.57 | |
| Ascendis Pharma A S (ASND) | 7.9 | $31M | 276k | 112.61 | |
| Tg Therapeutics (TGTX) | 6.1 | $24M | 2.5M | 9.84 | |
| Apellis Pharmaceuticals (APLS) | 6.1 | $24M | 900k | 26.79 | |
| Chemocentryx | 5.9 | $23M | 580k | 40.18 | |
| GlaxoSmithKline | 5.0 | $20M | 511k | 38.89 | |
| Deciphera Pharmaceuticals | 4.3 | $17M | 414k | 41.17 | |
| AstraZeneca (AZN) | 4.0 | $16M | 353k | 44.66 | |
| BioCryst Pharmaceuticals (BCRX) | 3.8 | $15M | 7.5M | 2.00 | |
| Amarin Corporation | 3.5 | $14M | 3.5M | 4.00 | |
| Spdr S&p 500 Etf Tr option | 3.5 | $14M | 600.00 | 22755.00 | |
| Ensign (ENSG) | 3.4 | $13M | 357k | 37.66 | |
| Hca Holdings (HCA) | 2.3 | $9.1M | 101k | 89.85 | |
| Model N (MODN) | 2.1 | $8.3M | 374k | 22.21 | |
| Sanofi-Aventis SA (SNY) | 2.1 | $8.3M | 190k | 43.72 | |
| Fate Therapeutics (FATE) | 1.7 | $6.8M | 306k | 22.21 | |
| Dex (DXCM) | 1.3 | $5.3M | 20k | 269.28 | |
| Taro Pharmaceutical Industries (TARO) | 1.2 | $4.7M | 77k | 61.20 | |
| Kadmon Hldgs | 1.0 | $4.1M | 975k | 4.19 | |
| Pennant Group (PNTG) | 1.0 | $4.0M | 282k | 14.16 | |
| Momenta Pharmaceuticals | 1.0 | $4.0M | 147k | 27.20 | |
| Radius Health | 1.0 | $3.9M | 301k | 13.00 | |
| Acceleron Pharma | 1.0 | $3.8M | 42k | 89.87 | |
| Biohaven Pharmaceutical Holding | 0.9 | $3.6M | 106k | 34.03 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $2.7M | 90k | 29.94 | |
| GenMark Diagnostics | 0.5 | $2.2M | 524k | 4.12 | |
| Cytokinetics (CYTK) | 0.5 | $2.1M | 182k | 11.79 | |
| Community Health Systems (CYH) | 0.5 | $1.9M | 580k | 3.34 | |
| Envista Hldgs Corp (NVST) | 0.4 | $1.6M | 109k | 14.94 | |
| Oxford Immunotec Global | 0.4 | $1.6M | 172k | 9.26 | |
| Agile Therapeutics | 0.3 | $1.3M | 712k | 1.86 | |
| Myokardia | 0.3 | $1.3M | 28k | 46.88 | |
| Albireo Pharma | 0.3 | $1.3M | 78k | 16.37 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.3 | $1.3M | 210k | 5.99 | |
| Immunovant (IMVT) | 0.3 | $1.2M | 77k | 15.56 | |
| Liquidia Technologies (LQDA) | 0.3 | $1.2M | 245k | 4.71 | |
| Heska Corporation | 0.3 | $1.1M | 21k | 55.32 | |
| Otonomy | 0.3 | $1.1M | 562k | 1.97 | |
| Dicerna Pharmaceuticals | 0.3 | $1.1M | 60k | 18.37 | |
| Teligent | 0.3 | $1.1M | 3.9M | 0.28 | |
| Scpharmaceuticals (SCPH) | 0.2 | $980k | 132k | 7.40 | |
| Cyclerion Therapeutics | 0.2 | $893k | 337k | 2.65 | |
| Affimed Therapeutics B V | 0.2 | $886k | 561k | 1.58 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $812k | 72k | 11.34 | |
| Artara Therapeutics | 0.2 | $747k | 33k | 23.00 | |
| Inflarx Nv (IFRX) | 0.2 | $747k | 196k | 3.82 | |
| Sesen Bio | 0.2 | $729k | 1.3M | 0.56 | |
| Aquestive Therapeutics (AQST) | 0.2 | $657k | 300k | 2.19 | |
| Igm Biosciences (IGMS) | 0.1 | $549k | 9.8k | 56.19 | |
| Amarin Corp Plc option | 0.1 | $537k | 1.5k | 358.00 | |
| Macrogenics (MGNX) | 0.1 | $535k | 92k | 5.82 | |
| Puma Biotechnology (PBYI) | 0.1 | $492k | 58k | 8.45 | |
| Eiger Biopharmaceuticals | 0.1 | $474k | 70k | 6.80 | |
| BioDelivery Sciences International | 0.1 | $465k | 123k | 3.79 | |
| eHealth (EHTH) | 0.1 | $444k | 3.2k | 140.82 | |
| Align Technology Inc. cmn | 0.1 | $423k | 100.00 | 4230.00 | |
| Pfenex | 0.1 | $408k | 46k | 8.81 | |
| Amarin Corp Plc option | 0.1 | $374k | 10k | 36.54 | |
| Air Lease Corp cl a | 0.0 | $121k | 200.00 | 605.00 | |
| Zogenix Inc call | 0.0 | $55k | 55.00 | 1000.00 | |
| Illumina (ILMN) | 0.0 | $46k | 170.00 | 270.59 | |
| Agilent Technologies Inc C ommon (A) | 0.0 | $36k | 500.00 | 72.00 | |
| Optinose | 0.0 | $22k | 5.0k | 4.39 | |
| Bristol Myers Squibb Co right 12/30/2030 (CELG.R) | 0.0 | $3.0k | 6.0k | 0.50 |
